Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab
- Status
- COMPLETED
- Phase
- PHASE1
Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib
- Status
- COMPLETED
- Phase
- PHASE2
MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER)
- Status
- COMPLETED
- Phase
- PHASE2
Scleroderma Treatment With Autologous Transplant (STAT) Study
- Status
- COMPLETED
- Phase
- PHASE2
S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors
- Status
- UNKNOWN
- Phase
- PHASE2
Weekly Paclitaxel and Cyclophosphamide in Metronomic Administration : Dose Escalation Study of Weekly Paclitaxel
- Status
- COMPLETED
- Phase
- PHASE1
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Intensified Rituimab Prephase Before FCR in Untreated B-CLL
- Status
- COMPLETED
- Phase
- PHASE2
Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)
- Status
- TERMINATED
- Phase
- PHASE1
Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2